Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 120.66%1.58B | 17.38%1.84B | -13.11%714.23M | -31.40%1.56B | -32.85%822.03M | -23.46%2.28B | -19.16%1.22B | 7.64%2.98B | 16.16%1.51B | 55.04%2.77B |
| Operating income | 120.66%1.58B | 17.38%1.84B | -13.11%714.23M | -31.40%1.56B | -32.85%822.03M | -23.46%2.28B | -19.16%1.22B | 7.64%2.98B | 16.16%1.51B | 55.04%2.77B |
| Cost of sales | -126.46%-1.52B | -19.01%-1.74B | 14.23%-670.45M | 32.05%-1.46B | 31.54%-781.72M | 20.02%-2.15B | 16.56%-1.14B | -8.42%-2.69B | -16.02%-1.37B | -49.27%-2.48B |
| Operating expenses | -126.46%-1.52B | -19.01%-1.74B | 14.23%-670.45M | 32.05%-1.46B | 31.54%-781.72M | 20.02%-2.15B | 16.56%-1.14B | -8.42%-2.69B | -16.02%-1.37B | -49.27%-2.48B |
| Gross profit | 31.94%57.77M | -6.25%94.53M | 8.63%43.79M | -20.25%100.84M | -50.99%40.31M | -55.83%126.45M | -43.53%82.25M | 0.86%286.29M | 17.54%145.65M | 134.30%283.84M |
| Administrative expenses | -22.58%-47.45M | 6.32%-82.17M | -18.80%-38.7M | 4.31%-87.72M | 28.95%-32.58M | 28.13%-91.67M | 28.72%-45.86M | -9.23%-127.54M | -20.10%-64.33M | -55.72%-116.76M |
| Impairment and provision | -105.95%-50K | 133.94%282K | 1,348.28%840K | -20.78%-831K | 108.79%58K | -28.12%-688K | -158.30%-660K | 70.66%-537K | 162.61%1.13M | -16.78%-1.83M |
| -Other impairment is provision | -105.95%-50K | 133.94%282K | 1,348.28%840K | -20.78%-831K | 108.79%58K | -28.12%-688K | -158.30%-660K | 70.66%-537K | 162.61%1.13M | -16.78%-1.83M |
| Special items of operating profit | -85.97%671K | -36.23%6.32M | -11.72%4.78M | -8.64%9.91M | -34.63%5.42M | 119.52%10.85M | 410.79%8.29M | -91.81%4.94M | -94.59%1.62M | 2,045.70%60.34M |
| Operating profit | 2.28%10.95M | -14.61%18.96M | -18.94%10.7M | -50.60%22.2M | -70.01%13.2M | -72.45%44.94M | -47.64%44.02M | -27.67%163.16M | -14.67%84.07M | 375.81%225.59M |
| Financing cost | -351.55%-2.19M | 72.26%-826K | 76.79%-485K | 56.58%-2.98M | 35.29%-2.09M | 0.71%-6.86M | -14.05%-3.23M | 28.65%-6.91M | 40.54%-2.83M | 6.49%-9.68M |
| Earning before tax | -14.30%8.76M | -5.67%18.13M | -8.05%10.22M | -49.52%19.23M | -72.75%11.11M | -75.63%38.09M | -49.79%40.79M | -27.63%156.25M | -13.35%81.24M | 482.62%215.91M |
| Tax | -63.86%-1.61M | -10.89%-2.18M | 33.89%-985K | 73.91%-1.97M | 78.34%-1.49M | 71.69%-7.54M | 50.17%-6.88M | 2.77%-26.62M | -22.02%-13.81M | -218.27%-27.37M |
| After-tax profit from continuing operations | -22.64%7.14M | -7.56%15.95M | -4.05%9.23M | -43.51%17.26M | -71.62%9.62M | -76.43%30.55M | -49.71%33.91M | -31.24%129.64M | -18.21%67.43M | 562.53%188.54M |
| Earning after tax | -22.64%7.14M | -7.56%15.95M | -4.05%9.23M | -43.51%17.26M | -71.62%9.62M | -76.43%30.55M | -49.71%33.91M | -31.24%129.64M | -18.21%67.43M | 562.53%188.54M |
| Profit attributable to shareholders | -22.64%7.14M | -7.56%15.95M | -4.05%9.23M | -43.51%17.26M | -71.62%9.62M | -76.43%30.55M | -49.71%33.91M | -31.24%129.64M | -18.21%67.43M | 562.53%188.54M |
| Basic earnings per share | -22.22%0.014 | -8.57%0.032 | -5.26%0.018 | -42.62%0.035 | -72.06%0.019 | -76.45%0.061 | -49.63%0.068 | -31.30%0.259 | -18.18%0.135 | 471.21%0.377 |
| Diluted earnings per share | -22.22%0.014 | -8.57%0.032 | -5.26%0.018 | -42.62%0.035 | -72.06%0.019 | -76.45%0.061 | -49.63%0.068 | -31.30%0.259 | -18.18%0.135 | 471.21%0.377 |
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants | -- | Rosenmei Certified Public Accountants |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.